According to GlobalData, MEMO 3D RECHORD is one of 30 product lines sold in the US cardiac valve repair market; these product lines are sold by 5 different manufacturers. The price of the MEMO 3D RECHORD device can be viewed in GlobalData’s micro pricing report and can be retrieved according to purchase date, facility type, bed size, and geographical region. Buy the report here.
Smarter leaders trust GlobalData
The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches.
In addition, the final selling pricing of medical devices is also impacted by the discounting policy of the manufacturer. Companies such as Corcym apply discounts for their devices based on their internal business strategy, inventory control, and monthly or quarterly sales targets. In addition, sale location can also affect the final selling price of a device, both in terms of geographical region and facility type. Prices for the same medical device often vary in hospitals and health systems versus outside of hospital facilities, for example if high volume healthcare institutions can negotiate discounts or rebates based on large purchase sizes.
Corcym overview
Corcym Srl (Corcym) is a manufacturer and supplier of medical devices for structural heart diseases. The company’s product range includes surgical sutureless heart valves, mechanical, stented and stentless valves, and ascending aortic prostheses for aortic valve replacement. It also offers semi-rigid and flexible annuloplasty rings. Corcym markets its products under Perceval, Solo Smart, Bicarbonate, Crown PRT, Crabomedics, Annuloflex, and other brands. The company has an operational presence in Burnaby, Canada. Corcym is headquartered in Milan, Italy.
For a complete picture of MEMO 3D RECHORD, Cardiac Valve Repair pricing in the US, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.
